Morepen Laboratories Ltd

NSE: MOREPENLAB · BSE: 500288 · Pharmaceuticals & Biotechnology · 33 announcements

Share price: ₹148.38
Market cap: ₹8,131 Cr
Revenue (annual): ₹1,806 Cr
Net profit (annual): ₹94.88 Cr
P/E (TTM): 57.9×Sector 47.4×
Promoter holding: 35.65%+0.00% QoQ
FII holding: 1.46%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

4 Aug 2026 14:03 IST BSE

Morepen Laboratories Results Update

Morepen Laboratories reported record Q1 FY27 revenue of Rs. 575.31 Crore, up 34% YoY. Net profit surged 394% to Rs. 56.35 Crore following CDMO commercialization.

Value: ₹575.3 Cr

Read the filing ↗

27 May 2026 08:22 IST NSE

Results Update

Morepen Laboratories Results Update

Morepen Labs reported a 69% YoY net profit rise to ₹20 Crore for Q4 FY26. Strong growth in medical devices and CDMO execution support long-term visibility.

Value: ₹20.00 Cr

Read the filing ↗